Growth Metrics

Organogenesis Holdings (ORGO) Income from Continuing Operations (2017 - 2025)

Historic Income from Continuing Operations for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to $21.6 million.

  • Organogenesis Holdings' Income from Continuing Operations rose 7490.07% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.7 million, marking a year-over-year decrease of 3162.6%. This contributed to the annual value of -$9.9 million for FY2024, which is 29935.29% down from last year.
  • According to the latest figures from Q3 2025, Organogenesis Holdings' Income from Continuing Operations is $21.6 million, which was up 7490.07% from -$9.4 million recorded in Q2 2025.
  • Over the past 5 years, Organogenesis Holdings' Income from Continuing Operations peaked at $51.0 million during Q4 2021, and registered a low of -$18.8 million during Q1 2025.
  • For the 5-year period, Organogenesis Holdings' Income from Continuing Operations averaged around $5.2 million, with its median value being $3.2 million (2023).
  • Per our database at Business Quant, Organogenesis Holdings' Income from Continuing Operations surged by 137302.33% in 2023 and then tumbled by 79728.57% in 2025.
  • Organogenesis Holdings' Income from Continuing Operations (Quarter) stood at $51.0 million in 2021, then crashed by 85.32% to $7.5 million in 2022, then crashed by 107.59% to -$568000.0 in 2023, then tumbled by 436.27% to -$3.0 million in 2024, then skyrocketed by 808.04% to $21.6 million in 2025.
  • Its Income from Continuing Operations was $21.6 million in Q3 2025, compared to -$9.4 million in Q2 2025 and -$18.8 million in Q1 2025.